Department of Pediatrics, Division of Pediatric Emergency, Faculty of Medicine, Gazi University, Ankara, Turkey.
Iran J Allergy Asthma Immunol. 2021 Feb 11;20(1):125-128. doi: 10.18502/ijaai.v20i1.5420.
Pharmacological anisocoria is a rare but benign condition. This paper presents an eleven-year-old patient with asthma who developed ipratropium bromide-associated anisocoria during nebulizer treatment. Hypotheses regarding the possible causes of anisocoria are discussed and precautions to be taken during treatment are presented. To prevent the development of anisocoria, it was found that it is important to use the appropriate mask during nebulizer treatment, to place the mask on the face properly, and, if possible, to administer drugs by closing the eyes. Further, it is recommended that patients undergo an ophthalmological examination before discharge and that they and their families be informed that the condition is temporary.
药物性瞳孔不等大是一种罕见但良性的情况。本文介绍了一例 11 岁哮喘患儿，在接受雾化治疗时出现了溴化异丙托品相关的瞳孔不等大。讨论了瞳孔不等大可能的原因，并提出了治疗时应采取的预防措施。为了防止瞳孔不等大的发生，研究发现，在雾化治疗过程中使用合适的面罩、正确放置面罩以及在可能的情况下闭眼给药非常重要。此外，建议在出院前对患者进行眼科检查，并告知患者及其家属这种情况是暂时的。
